Clinical Trial Update: Antibodies to Digoxin for Bipolar Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial testing antibodies against digoxin for Bipolar Disorder has completed, with results to be reported to determine potential efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Antibodies to Digoxin (anti-digoxin antibodies)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED